Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
about
Diet, microbiome, and the intestinal epithelium: an essential triumvirate?Role of enteric neurotransmission in host defense and protection of the gastrointestinal tractDynamic changes in mucus thickness and ion secretion during Citrobacter rodentium infection and clearanceEnteric glia promote intestinal mucosal healing via activation of focal adhesion kinase and release of proEGFMuc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.Modulatory effects of vasoactive intestinal peptide on intestinal mucosal immunity and microbial community of weaned piglets challenged by an enterotoxigenic Escherichia coli (K88)Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis.Enteric glia cells attenuate cytomix-induced intestinal epithelial barrier breakdown.Guanylate cyclase C limits systemic dissemination of a murine enteric pathogen.Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium.Emerging neuropeptide targets in inflammation: NPY and VIPThe enteric nervous system as a regulator of intestinal epithelial barrier function in health and disease.The digestive neuronal-glial-epithelial unit: a new actor in gut health and disease.Review article: intestinal barrier dysfunction and central nervous system disorders--a controversial association.Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption.Sensory neuron regulation of gastrointestinal inflammation and bacterial host defence.VIP and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.Vasoactive intestinal peptide prevents PKCε-induced intestinal epithelial barrier disruption during EPEC infection.Vasoactive intestinal polypeptide regulates barrier function via mast cells in human intestinal follicle-associated epithelium and during stress in rats.Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.A gut feeling: Microbiome-brain-immune interactions modulate social and affective behaviors.Colonic levels of vasoactive intestinal peptide decrease during infection and exogenous VIP protects epithelial mitochondria against the negative effects of IFNγ and TNFα induced during Citrobacter rodentium infection
P2860
Q26823069-CBD101DD-4174-431C-BAA6-07429805AD54Q26827692-37229DCF-0475-4D25-A239-15F3A7C87959Q27335169-ECBFF427-A5E5-475D-BE37-9F7A81C52712Q30501389-95DD1E86-E634-45E9-973F-A4D646ACD90FQ33582232-0CBA4C3E-B3D4-4FAB-9A26-7D7A9FC48B18Q34015572-67BC05B8-E9F0-4277-9FCB-47882B6BA16BQ34320335-5B4F0324-A3BB-4DFC-B4DD-B6B00441DC99Q34809293-5E276D07-F67E-4A6A-9A99-D4D80EF41868Q34978181-D0D22631-B259-4C8D-8A58-E04C1B514E27Q34979549-7E631656-0FD5-47E9-B635-81A4AFF24A82Q35620108-946C84B1-6A8D-46CB-A893-7C4A08F7CFB6Q36499693-E3AE8756-C90C-48F3-9DD2-9B6F3D60C544Q36923640-5C9AF1A2-4E77-4F1D-94D8-0DFB56BE5831Q37798825-5C12D83D-6299-4C42-823C-EC72D5905D1DQ38060991-8A129BCA-1940-4180-92D4-A5CE3B293CA8Q38254985-892D3BB8-05D3-4EFD-96DE-0ACA17AF00A3Q38735104-A87681E7-4BC1-4652-8DBB-2D01669E50E4Q39117205-DDB31AC1-5149-4847-B667-B352DB3B3CE2Q39309675-9F600478-0992-440F-BAC2-780B37471A6DQ39388328-C814BB6F-8F17-4795-971F-22D20D13D6ECQ41602366-44DE9C3C-9CAF-47EF-ABA4-3578B27FB08DQ43517624-57D075D9-36B1-4B70-AC72-95F2C0047E38Q47677851-34E798FD-44A7-43D0-B752-C9BCEA469E87Q50087217-CBFBF88E-837B-4DCC-BBF6-3B8DBAB4E9BBQ58699103-A60B0117-C973-465C-A6C4-9D0ABD369D7B
P2860
Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Vasoactive intestinal peptide ...... ter rodentium-induced colitis.
@en
Vasoactive intestinal peptide ...... ter rodentium-induced colitis.
@nl
type
label
Vasoactive intestinal peptide ...... ter rodentium-induced colitis.
@en
Vasoactive intestinal peptide ...... ter rodentium-induced colitis.
@nl
prefLabel
Vasoactive intestinal peptide ...... ter rodentium-induced colitis.
@en
Vasoactive intestinal peptide ...... ter rodentium-induced colitis.
@nl
P2093
P2860
P356
P1476
Vasoactive intestinal peptide ...... ter rodentium-induced colitis.
@en
P2093
A M J Buchan
K Jacobson
V S Conlin
P2860
P304
P356
10.1152/AJPGI.90551.2008
P577
2009-08-06T00:00:00Z